All ProductsDisplaying Products Alphabetically by Name (D)
| Cat. No. | 产品名称/活性 |
|---|---|
| 2902 | D 4476 |
| Selective CK1 inhibitor. Also inhibits TGF-βRI | |
| 1437 | D609 |
| Selective PC-PLC inhibitor | |
| 7444 | DA ZP1 |
| Fluorogenic Zn(II) sensor for isolation of stem cell derived β cells | |
| 7756 | DAF FM diacetate |
| Cell permeable photostable nitric oxide (NO) fluorescent indicator | |
| 1171 | DAMGO |
| Selective μ agonist | |
| 0482 | 4-DAMP |
| Muscarinic M3 antagonist | |
| 5748 | DAPI |
| Blue-fluorescent DNA stain / dye. Used for: nuclear counterstain, fixed and live-cell staining, assessing apoptosis. Application: flow cytometry, confocal microscopy, immunofluorescence (IHC, ICC), ISH | |
| 2634 | DAPT |
| γ-secretase inhibitor; induces neuronal differentiation; blocks Notch signaling | |
| TB2634-RMU | DAPT |
| DAPT synthesized to Ancillary Material Grade | |
| 7921 | DBCO-NHS |
| Amine reactive and azide reactive building block | |
| 6175 | DBHDA |
| Reagent for synthetic biology; converts cysteine to dehydroalanine | |
| 8142 | DBIA 最新 |
| Chemoproteomic reagent, binds with reactive cysteines and labels with desthiobiotin | |
| 5095 | DBM 1285 dihydrochloride |
| p38 MAPK inhibitor; anti-inflammatory | |
| 4489 | DBZ |
| γ-secretase inhibitor; inhibits Notch pathway | |
| 5357 | DC 260126 |
| FFA1 (GPR40) antagonist | |
| 7176 | DC-Cholesterol hydrochloride |
| Cationic cholesterol derivative | |
| 2755 | DCA |
| Mitochondrial pyruvate dehydrogenase kinase (PDK) inhibitor | |
| 1422 | DCEBIO |
| Activates Cl- conductance and hKCa3.1 channels | |
| 0975 | DCG IV |
| Highly potent group II mGlu agonist; also NMDA agonist | |
| 7285 | DCLK1-IN-1 |
| Potent and selective doublecortin like kinase 1/2 (DCLK1/2) inhibitor; orally bioavailable | |
| 1302 | (S)-3,4-DCPG |
| Potent and selective mGlu8a agonist | |
| 1540 | DCPIB |
| Blocker of VRAC/ICl, swell | |
| 7160 | DD 03-171 |
| Potent and selective BTK Degrader (PROTAC®) | |
| 5077 | DDR1-IN-1 dihydrochloride |
| Selective DDR1 inhibitor | |
| 2558 | 10-DEBC hydrochloride |
| Selective Akt/PKB inhibitor | |
| 8009 | Z-DEVD-FMK Caspase-3 Inhibitor |
| Caspase-3 Inhibitor | |
| 5609 | DFHBI |
| GFP fluorophore mimic for imaging RNA in living cells; activated by binding Spinach2 and Broccoli aptamers | |
| 5610 | DFHBI 1T |
| GFP fluorophore mimic for imaging RNA in living cells; activated by binding Spinach2 and Broccoli aptamers | |
| 6434 | DFHO |
| RFP fluorophore mimic for imaging RNA in living cells; activated by binding Corn aptamers | |
| 2761 | DFMO |
| Ornithine decarboxylase inhibitor | |
| 6240 | DG 041 |
| Potent and selective EP3 antagonist; antiplatelet and antithrombotic | |
| 0112 | γDGG |
| Broad spectrum glutamatergic antagonist | |
| 4599 | 3,5-DHBA |
| Selective HCA1 agonist | |
| 8168 | DHC-156 |
| Brachyury down modulator | |
| 0342 | (RS)-3,5-DHPG |
| Selective group I mGlu agonist | |
| 0805 | (S)-3,5-DHPG |
| Selective group I mGlu agonist; active enantiomer of 3,5-DHPG (Cat. No. 0342) | |
| 4523 | DIDS |
| Chloride channel blocker; TRPV1 modulator; RAD51 recombinase inhibitor | |
| 6377 | DIM-C-pPhOH |
| Nur77 antagonist | |
| 0794 | DIPPA hydrochloride |
| Selective and irreversible κ antagonist | |
| 7082 | DL 175 |
| Potent and selective GPR84 agonist | |
| 3154 | DL-Dithiothreitol |
| Maintains SH groups in the reduced state | |
| 8895 | DLin-KC2-DMA |
| Ionizable cationic lipid | |
| 7946 | DLin-MC3-DMA |
| Component of lipid nanoparticles (LNPs); ionizable cationic lipid | |
| 8874 | DMB 最新 |
| GSDMD (Gasdermin D) agonist, activator of pyroptosis, also GLP-1R agonist | |
| 3083 | DMCM hydrochloride |
| Benzodiazepine inverse agonist | |
| 7944 | DMG-PEG 2000 |
| PEGylated myristoyl diglyceride; commonly used in the formation of lipid nanoparticles (LNPs) | |
| 4126 | DMH-1 |
| Selective ALK2 inhibitor | |
| 5580 | DMH2 |
| Type I BMP receptor inhibitor | |
| 7764 | DMHBO+ |
| Fluorescent upon binding to Chili aptamer; for imaging RNA in cells | |
| 6315 | DMNB-caged-Serine |
| Caged serine; excited by visible blue light | |
| 5948 | DMNPE-4 AM-caged-calcium |
| Calcium cage; cell permeable | |
| 5157 | DMNPE-caged ATP diammonium salt |
| Caged ATP | |
| 4408 | DMOG |
| Prolyl hydroxylase inhibitor | |
| 3176 | DMSO, sterile filtered |
| DMSO, sterile filtered, wide ranging applications in cell culture, cryopreservation and organic chemistry. Solvent for polar and nonpolar compounds | |
| 7726 | DMSO, Cell Cryopreserve Grade |
| Intracellular cryoprotective agent | |
| 5601 | DMXAA |
| mSTING agonist; induces antitumor immunological responses | |
| 0189 | DNQX |
| Selective non-NMDA iGluR antagonist | |
| 2312 | DNQX disodium salt |
| Selective non-NMDA iGluR antagonist; water-soluble salt of DNQX (Cat. No. 0189) | |
| 7175 | DOPE |
| Liposome/lipoplex transfection enhancer | |
| 7179 | DOTAP |
| Cationic agent for liposome and LNP formation | |
| 0439 | DPCPX |
| Selective A1 antagonist | |
| 1431 | DPDPE |
| Selective δ agonist | |
| 1494 | DPN |
| Highly potent ERβ agonist | |
| 2533 | DPO-1 |
| Blocker of KV1.5 channel and IKur current | |
| 2783 | DPPI 1c hydrochloride |
| Dipeptidyl peptidase IV (DPP-IV) inhibitor | |
| 6903 | DPTIP |
| Potent and selective N-SMase2 inhibitor; brain penetrant | |
| 7628 | DPTN |
| Potent and selective A3 adenosine receptor antagonist | |
| 4491 | DQP 1105 |
| GluN2C/GluN2D-selective NMDA antagonist | |
| 5005 | DR 4485 hydrochloride |
| High affinity and selective 5-HT7 antagonist; orally bioavailable | |
| 5548 | DREADD agonist 21 |
| Potent hM3Dq and hM4Di DREADD agonist; blood brain barrier penetrant | |
| 6422 | DREADD agonist 21 dihydrochloride |
| Potent hM3Dq and hM4Di DREADD agonist; water soluble version of DREADD agonist 21 (Cat. No. 5548) | |
| 3610 | (R)-DRF053 dihydrochloride |
| Potent CK1 inhibitor; also inhibits cyclin-dependent kinases | |
| 3679 | DS2 |
| Positive allosteric modulator of GABAA receptors; displays subunit selectivity | |
| 2958 | DSP-4 |
| Adrenergic neurotoxin | |
| 7943 | DSPC |
| Neutral phospholipid; component of lipid nanoparticles (LNPs) | |
| 8837 | DSPE-PEG 2000 Azide |
| PEGylated DSPE with azide reactive group | |
| 8838 | DSPE-PEG 2000 Biotin |
| Biotinylated DSPE PEG lipid | |
| 7947 | DSPE-PEG 2000 Maleimide |
| PEGylated DSPE with a maleimide reactive group | |
| 4809 | DSR 6434 |
| Potent TLR7 agonist | |
| 7414 | DSRM-3716 |
| Potent and reversible SARM1 NAD hydrolase inhibitor | |
| 8070 | DX3-213B |
| Potent NDUFS7 antagonist | |
| 5656 | DY 268 |
| Potent FXR antagonist | |
| 2266 | DY131 |
| Agonist selective for estrogen-related receptors ERRβ and ERRγ | |
| TB4703-RMU | DZNep HCl |
| 3-Deazaneplanocin A hydrochloride synthesized to Ancillary Material Grade | |
| 7223 | Dabrafenib mesylate |
| Potent and selective B-Raf, CDK16 and NEK9 inhibitor; anticancer; also targets human proteins in the SARS-CoV-2 interactome | |
| 6231 | Dacomitinib |
| Potent irreversible pan ErbB inhibitor | |
| 0507 | Dantrolene, sodium salt |
| Ca2+ release inhibitor | |
| 6902 | Dapansutrile |
| NLRP3 inflammasome inhibitor; disrupts inflammasome formation | |
| 3917 | Daptomycin |
| Antibiotic; inhibits protein, DNA and RNA synthesis in gram-positive bacteria | |
| 6755 | Darapladib |
| Potent lp-PLA2 inhibitor | |
| 6710 | Darunavir |
| Highly potent HIV protease inhibitor | |
| 6793 | Dasatinib |
| Highly potent pan-Src/Bcr-Abl inhibitor | |
| 1467 | Daunorubicin hydrochloride |
| DNA topoisomerase II inhibitor | |
| 6779 | Davunetide |
| Highly potent active component of ADNP; prevents amyloid β aggregation; active in vivo | |
| 4488 | 1-Deazaadenosine |
| Adenosine deaminase inhibitor | |
| 8986 | Deazaflavin, Alkyne 最新 |
| Photosensitizer for proximity labeling experiments, Alkyne reactive group | |
| 8987 | Deazaflavin, Haloalkane 最新 |
| Photosensitizer for proximity labeling experiments, NHS reactive group | |
| 4703 | 3-Deazaneplanocin A hydrochloride |
| EZH2 histone methyltransferase inhibitor | |
| 3501 | Decanoyl-RVKR-CMK |
| Subtilisin/Kex2p-like proprotein convertase inhibitor | |
| 2624 | Decitabine |
| DNA methyltransferase inhibitor | |
| 7305 | Defactinib |
| Potent and selective FAK and Pyk2 inhibitor | |
| 5764 | Deferoxamine mesylate |
| Iron chelator; also hypoxia mimetic and neuroprotectant | |
| 5424 | Deltarasin |
| High affinity PDEδ-KRas interaction inhibitor; binds to PDEδ | |
| 1180 | [D-Ala2]-Deltorphin II |
| Selective δ agonist peptide | |
| 1819 | Demethylasterriquinone B1 |
| Selective insulin RTK activator | |
| 4515 | 2-Deoxy-D-glucose |
| Non-metabolizable glucose analog; inhibits glucose metabolism | |
| 7193 | Deschloroclozapine |
| High affinity and highly potent activator of hM3Dq and hM4Di DREADDs; rapidly blood brain barrier penetrant | |
| 3328 | Desformylflustrabromine hydrochloride |
| Positive allosteric modulator of α4β2 nAChRs; also muscle-type nAChR inhibitor | |
| 3067 | Desipramine hydrochloride |
| Selective inhibitor of noradrenalin transporters | |
| 3396 | Desmopressin |
| Synthetic vasopressin analog; V1B and V2 agonist | |
| 2304 | Devazepide |
| Selective, orally active CCK1 receptor antagonist | |
| 1126 | Dexamethasone |
| Anti-inflammatory glucocorticoid | |
| TB1126-RMU | Dexamethasone |
| Dexamethasone synthesized to Ancillary Material Grade | |
| 2695 | Dexfenfluramine hydrochloride |
| 5-HT reuptake inhibitor; also stimulates 5-HT release | |
| 2749 | Dexmedetomidine hydrochloride |
| Potent, highly selective α2 agonist. Active isomer of medetomidine (Cat. No. 5160) | |
| 3857 | Dexrazoxane hydrochloride |
| Topoisomerase II inhibitor | |
| 7324 | Di 4 ANEPPS |
| Voltage-sensitive probe; used to detect changes in membrane potential in electrophysiology protocols | |
| 5702 | DiD perchlorate |
| Lipophilic fluorescent dye. Used for: membrane labeling. Application: fluorescent microscopy, flow cytometry. Suitable for live cell imaging | |
| 6882 | DiFMUP |
| Fluorescent phosphatase substrate | |
| 1141 | Dibutyryl-cAMP, sodium salt |
| Cell-permeable cAMP analog | |
| 3698 | 5,7-Dichlorokynurenic acid sodium salt |
| Potent NMDA antagonist, acts at glycine site; sodium salt of 5,7-Dichlorokynurenic acid | |
| 4454 | Diclofenac sodium salt |
| Cyclooxygenase inhibitor; NSAID | |
| 0468 | N1,N11-Diethylnorspermine tetrahydrochloride |
| Spermine and spermidine acetyltransferase potentiator | |
| 7784 | Digoxigenin NHS ester |
| NHS ester hapten for labeling amino groups | |
| 7236 | Digoxigenin Tyramide |
| Reagent used for Tyramide Signal Amplification in IHC, ICC and ISH | |
| 4583 | Digoxin |
| Na+/K+ ATPase inhibitor | |
| 0884 | Dihydrexidine hydrochloride |
| Selective D1-like agonist | |
| 2349 | Dihydro-β-erythroidine hydrobromide |
| α4β2, muscle type and Torpedo nAChR antagonist | |
| 0111 | Dihydrokainic acid |
| EAAT2 (GLT-1)-selective non-transportable inhibitor of L-glutamate and L-aspartate uptake | |
| 3826 | 7,8-Dihydroxyflavone |
| TrkB agonist | |
| 0481 | Dilazep dihydrochloride |
| Adenosine uptake inhibitor | |
| 0685 | Diltiazem hydrochloride |
| CaV1.x blocker | |
| 1425 | (S)-(+)-Dimethindene maleate |
| Selective M2 antagonist | |
| 4027 | 16,16-Dimethyl Prostaglandin E2 |
| Synthetic prostaglandin E2 (Cat. No. 2296) derivative; regulates HSC development | |
| 7336 | Dinaciclib |
| Potent and selective inhibitor of CDK2, CDK5, CDK1 and CDK9 | |
| 3072 | Diphenhydramine hydrochloride |
| H1 antagonist | |
| 0504 | Diphenyleneiodonium chloride |
| GPR3 agonist; also inhibits NOS and NADPH oxidases | |
| 6019 | Diprotin A |
| Dipeptidyl peptidase IV (DPP-IV) inhibitor | |
| 0691 | Dipyridamole |
| Adenosine transport inhibitor | |
| 7768 | Disulfide biotin azide |
| Azide-activated biotinylation reagent; labels alkyne moieties via copper-catalyzed click chemistry | |
| 3807 | Disulfiram |
| Reversibly stimulates SERCA Ca2+-ATPase; displays a range of other activities | |
| 0515 | Dobutamine hydrochloride |
| α1, β1 and β2 agonist | |
| 4056 | Docetaxel |
| Microtubule stabilizer | |
| 3687 | Docosahexaenoic acid |
| RXR agonist | |
| 3757 | Dofetilide |
| KV11.1 (hERG) channel blocker; inhibits rapid delayed rectifier K+ current (IKr) | |
| 4385 | Donepezil hydrochloride |
| Potent AChE inhibitor | |
| 6568 | Dooku 1 |
| Reversibly blocks Yoda1 activity; does not affect constitutive Piezo1 activity | |
| 3548 | Dopamine hydrochloride |
| Endogenous agonist at dopamine D1-5 receptors | |
| 3093 | Dorsomorphin dihydrochloride |
| Potent AMPK inhibitor; also BMP type I receptor inhibitor | |
| 2964 | Doxazosin mesylate |
| α1 antagonist | |
| 2252 | Doxorubicin hydrochloride |
| Antitumor antibiotic agent. Inhibits DNA topoisomerase II | |
| 4090 | Doxycycline hyclate |
| Broad-spectrum MMP inhibitor; tetracycline derivative | |
| 4798 | (S)-Duloxetine hydrochloride |
| Potent 5-HT and NA reuptake inhibitor (SNRI); also blocks dopamine reuptake | |
| 6896 | Dynapyrazole A |
| Hedgehog signaling inhibitor; dynein inhibitor | |
| 6526 | Dynarrestin |
| Inhibitor of Hedgehog (Hh) signaling; inhibits cytoplasmic dynein | |
| 2897 | Dynasore |
| Non-competitive dynamin inhibitor | |
| 4222 | Dynole 34-2 |
| Dynamin I inhibitor | |
| 3195 | Dynorphin A |
| Endogenous κ agonist |
Tocris Products by Catalog Number
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900